Navigation Links
Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
Date:5/20/2008

gh grants provided by Dey, L.P., which developed and markets Perforomist(TM) Inhalation Solution. Dey, L.P. is a subsidiary of Mylan Inc. (NYSE: MYL).

About Perforomist(TM) Inhalation Solution

Indication

Perforomist(TM) Inhalation Solution is indicated for the long-term, twice- daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.

Important Safety Information

Perforomist(TM) Inhalation Solution belongs to a class of medications known as long-acting beta2-adrenergic agonists (LABAs). LABAs may increase the risk of asthma-related death. Data from a large placebo-controlled US study comparing the safety of another LABA (salmeterol) or placebo added to usual asthma therapy showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol may apply to formoterol (a LABA), the active ingredient in Perforomist(TM) Inhalation Solution.

Perforomist(TM) Inhalation Solution should not be used in patients with acutely deteriorating COPD or to treat acute symptoms. Acute symptoms should be treated with fast-acting rescue inhalers. Perforomist(TM) Inhalation Solution should not be used with other medications containing LABAs. Do not use more than one nebule twice daily. Perforomist(TM) Inhalation Solution should be used with caution in patients with cardiovascular disorders. Perforomist(TM) Inhalation Solution is not a substitute for inhaled or oral corticosteroids. The safety and efficacy of Perforomist(TM) Inhalation Solution in asthma has not been established.

In COPD clinical trials, the most common adverse events reported
'/>"/>

SOURCE Dey, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
2. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
3. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
4. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
5. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
6. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
7. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
8. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
9. Gene Therapy Provides Vision to People who Were Nearly Blind
10. Arpida Provides Further Comments on the Pivotal Phase III Trials
11. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... UPI ), a medical device company that develops, manufactures ... reported financial results for the first quarter of fiscal 2012 ... to $4.7 million in the fiscal first quarter ended June ... quarter a year ago.  The increase reflects continued strength in ...
... 28, 2011 Financial Highlights ($ in millions, except per ... $110.6 , 20.2% increase Total Net Product Revenue , ... , 27.5% increaseAldurazyme BioMarin Net Product Revenue* , ... 16.6% increaseFirdapse Net Product Revenue , $3.2 , $1.1GAAP ...
Cached Medicine Technology:Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 2Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 3Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 4Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 5Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 6Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 7Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012 8BioMarin Announces Second Quarter 2011 Financial Results 2BioMarin Announces Second Quarter 2011 Financial Results 3BioMarin Announces Second Quarter 2011 Financial Results 4BioMarin Announces Second Quarter 2011 Financial Results 5BioMarin Announces Second Quarter 2011 Financial Results 6BioMarin Announces Second Quarter 2011 Financial Results 7BioMarin Announces Second Quarter 2011 Financial Results 8BioMarin Announces Second Quarter 2011 Financial Results 9BioMarin Announces Second Quarter 2011 Financial Results 10BioMarin Announces Second Quarter 2011 Financial Results 11BioMarin Announces Second Quarter 2011 Financial Results 12BioMarin Announces Second Quarter 2011 Financial Results 13
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... ... MomAtLast.com , ... March 31, 2010 -- Phenomenal moms-helping-moms-to-be website MomAtLast.com announces a “ share your journey ... great resource for women of all ages who are trying to become parents – ...
... , ... to Increase Local Enrollment of Medical Clinical Trials , ... (PRWEB) March 29, 2010 -- In a move ... patient care site Accumed Research Associates of Garden City, NY on long Island has ...
... To ... offering a free virtual conference with 17 different presenters over two days on Saturday April ... free. , ... March 31, 2010 -- In honor of Autism Awareness month, momsfightingautism.com is offering a free ...
... ... with an exciting multi-media event at the Hilton Americas in Houston, Texas on March ... ... of CieAura Transparent Holographic Chips™, successfully launched its direct sales company with an exciting ...
... ... an internationally recognized leader in literacy research, remediation, and professional development, will help ... beginning April 1st, 2010. , ... San Luis Obispo, CA (Vocus) -- Lindamood-Bell Learning ...
... patients walking back to health with shelter dogs , TUESDAY, ... getting a new "leash" on life as they gain strength ... innovative program, called Cardiac Friends, is a partnership between ProHealth ... County, in Wisconsin. , "It,s a great way to help ...
Cached Medicine News:Health News:Share the Story Of How You Became a 'Mom At Last' And Win $100 2Health News:Accumed Research Associates Launches Official Website 2Health News:Accumed Research Associates Launches Official Website 3Health News:First Ever Virtual Autism Conference Featuring Temple Grandin and 16 speakers to discuss: “Things To Know About Autism” April 10th-11th. 2Health News:First Ever Virtual Autism Conference Featuring Temple Grandin and 16 speakers to discuss: “Things To Know About Autism” April 10th-11th. 3Health News:CieAura Launches Successfully with Over 3000 Attendees 2Health News:CieAura Launches Successfully with Over 3000 Attendees 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 2Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 4Health News:Man's Best Friend Helps Mend Broken Hearts 2Health News:Man's Best Friend Helps Mend Broken Hearts 3
... in gloves, Polymed has become even better. Polymed® ... of regular Polymed with the exciting addition of ... of antioxidants, which are vital to healthy skin. ... powder-free to reduce the potential for latex sensitization. ...
... DRAPE. Soft translucent material ... Latex finger cot with ... base. Full-width 50mm adhesive ... with finger lift for ...
CYSTOSCOPY "T". DRAPE...
Urological Drape Aggressive adhesive with no residue Latex-free finger cot Strong, low-glare matte finish film Non-linting, tear resistant poly release liner...
Medicine Products: